REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Generica Spol. S R.O. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Secondary Activities: Other Food Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Miscellaneous Store Retailers | All Other Business Support Services | All Other Schools and Instruction
Full name: Generica Spol. S R.O. Profile Updated: July 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Generica Spol. S R.O. is a company based in Slovakia, with its head office in Piestany. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on April 04, 1995. Generica Spol. S R.O. currently employs 25 - 49 (2025) people. The latest financial highlights indicate a net sales revenue drop of 17.42% in 2024. Its’ total assets recorded a growth of 8.75%. The enterprise’s net profit margin decreased by 3.51% in 2024.

Headquarters
Vrbovska, c.39
Piestany; Trnavsky; Postal Code: 92101

Contact Details: Purchase the Generica Spol. S R.O. report to view the information.

Website: http://www.generica.sk

Basic Information
Total Employees:
Purchase the Generica Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Generica Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Generica Spol. S R.O. report to view the information.
Incorporation Date:
April 04, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Generica Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.42%▼
Total Operating Revenue
-17.23%▼
Operating Profit
-40.32%▼
EBITDA
-35.57%▼
Net Profit/Loss for the Period
-37.81%▼
Total Assets
8.75%▲
Total Equity
6.68%▲
Operating Profit Margin
-5.08%▼
Net Profit Margin
-3.51%▼
Return on Equity (ROE)
-8.21%▼
Quick Ratio
-0.51%▼
Cash Ratio
0.01%▲

Similar companies

Saneca Pharmaceuticals A. S.
 
Hbm Pharma S.R.O.
Hartmann - Rico Spol. S R.O.
 
Hameln Rds S. R. O.
Bb Pharma S.R.O.
 
Unimed Pharma, Spol. S R.O.
Biomin, A.S.
 
Panacea, S.R.O.
Galvex, Spol. S R.O.
 
Farmacia Martin A.S.
Pharmagal, Spol. S.R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo